JP2006525359A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006525359A5 JP2006525359A5 JP2006514216A JP2006514216A JP2006525359A5 JP 2006525359 A5 JP2006525359 A5 JP 2006525359A5 JP 2006514216 A JP2006514216 A JP 2006514216A JP 2006514216 A JP2006514216 A JP 2006514216A JP 2006525359 A5 JP2006525359 A5 JP 2006525359A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- formula
- substituted
- compound according
- solvate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000217 alkyl group Chemical group 0.000 claims 38
- 150000001875 compounds Chemical class 0.000 claims 18
- 229910052739 hydrogen Inorganic materials 0.000 claims 8
- 239000001257 hydrogen Substances 0.000 claims 8
- -1 N-morpholinyl Chemical group 0.000 claims 7
- 150000002431 hydrogen Chemical class 0.000 claims 7
- 239000012453 solvate Substances 0.000 claims 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 6
- 239000000651 prodrug Substances 0.000 claims 6
- 229940002612 prodrugs Drugs 0.000 claims 6
- 125000004076 pyridyl group Chemical group 0.000 claims 6
- 150000003839 salts Chemical class 0.000 claims 6
- 239000011780 sodium chloride Substances 0.000 claims 6
- 125000003282 alkyl amino group Chemical group 0.000 claims 4
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 4
- 229910052736 halogen Inorganic materials 0.000 claims 4
- 150000002367 halogens Chemical class 0.000 claims 4
- OAKJQQAXSVQMHS-UHFFFAOYSA-N hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 claims 4
- 238000004519 manufacturing process Methods 0.000 claims 4
- 229910052757 nitrogen Inorganic materials 0.000 claims 4
- 125000004433 nitrogen atoms Chemical group N* 0.000 claims 4
- 125000003373 pyrazinyl group Chemical group 0.000 claims 4
- 125000002098 pyridazinyl group Chemical group 0.000 claims 4
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 4
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 3
- 239000002253 acid Substances 0.000 claims 3
- 125000004093 cyano group Chemical group *C#N 0.000 claims 3
- 125000005843 halogen group Chemical group 0.000 claims 3
- 125000002883 imidazolyl group Chemical group 0.000 claims 3
- 200000000018 inflammatory disease Diseases 0.000 claims 3
- 125000002757 morpholinyl group Chemical group 0.000 claims 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 3
- 125000004193 piperazinyl group Chemical group 0.000 claims 3
- 125000003386 piperidinyl group Chemical group 0.000 claims 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims 3
- 125000001424 substituent group Chemical group 0.000 claims 3
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 claims 3
- 206010003246 Arthritis Diseases 0.000 claims 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N Thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 claims 2
- 125000004103 aminoalkyl group Chemical group 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 125000004430 oxygen atoms Chemical group O* 0.000 claims 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 2
- 239000002904 solvent Substances 0.000 claims 2
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 claims 1
- 206010003210 Arteriosclerosis Diseases 0.000 claims 1
- 208000006673 Asthma Diseases 0.000 claims 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 1
- 206010012601 Diabetes mellitus Diseases 0.000 claims 1
- WASQWSOJHCZDFK-UHFFFAOYSA-N Diketene Chemical compound C=C1CC(=O)O1 WASQWSOJHCZDFK-UHFFFAOYSA-N 0.000 claims 1
- XYIBRDXRRQCHLP-UHFFFAOYSA-N Ethyl acetoacetate Chemical compound CCOC(=O)CC(C)=O XYIBRDXRRQCHLP-UHFFFAOYSA-N 0.000 claims 1
- 206010018634 Gouty arthritis Diseases 0.000 claims 1
- 206010021972 Inflammatory bowel disease Diseases 0.000 claims 1
- 102100000918 MAPK14 Human genes 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- ZSXGLVDWWRXATF-UHFFFAOYSA-N N,N-dimethylformamide dimethyl acetal Chemical compound COC(OC)N(C)C ZSXGLVDWWRXATF-UHFFFAOYSA-N 0.000 claims 1
- 208000001132 Osteoporosis Diseases 0.000 claims 1
- 208000002193 Pain Diseases 0.000 claims 1
- HKOOXMFOFWEVGF-UHFFFAOYSA-N Phenylhydrazine Chemical compound NNC1=CC=CC=C1 HKOOXMFOFWEVGF-UHFFFAOYSA-N 0.000 claims 1
- 206010037162 Psoriatic arthropathy Diseases 0.000 claims 1
- 206010039073 Rheumatoid arthritis Diseases 0.000 claims 1
- 206010048873 Traumatic arthritis Diseases 0.000 claims 1
- 201000000028 adult respiratory distress syndrome Diseases 0.000 claims 1
- 201000001320 atherosclerosis Diseases 0.000 claims 1
- 125000004432 carbon atoms Chemical group C* 0.000 claims 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 1
- 230000001684 chronic Effects 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 201000005569 gout Diseases 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- BAVYZALUXZFZLV-UHFFFAOYSA-N methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 claims 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N methylene dichloride Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims 1
- 230000000051 modifying Effects 0.000 claims 1
- 201000008482 osteoarthritis Diseases 0.000 claims 1
- 125000001715 oxadiazolyl group Chemical group 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 229940067157 phenylhydrazine Drugs 0.000 claims 1
- 201000004681 psoriasis Diseases 0.000 claims 1
- 201000001263 psoriatic arthritis Diseases 0.000 claims 1
- 230000002685 pulmonary Effects 0.000 claims 1
- 201000005404 rubella Diseases 0.000 claims 1
- 159000000000 sodium salts Chemical class 0.000 claims 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US46702903P | 2003-05-01 | 2003-05-01 | |
| PCT/US2004/013604 WO2004099156A1 (en) | 2003-05-01 | 2004-05-03 | Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006525359A JP2006525359A (ja) | 2006-11-09 |
| JP2006525359A5 true JP2006525359A5 (de) | 2007-04-26 |
| JP4601611B2 JP4601611B2 (ja) | 2010-12-22 |
Family
ID=33435012
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006514216A Expired - Fee Related JP4601611B2 (ja) | 2003-05-01 | 2004-05-03 | キナーゼインヒビターとして有用なアリール置換ピラゾール−アミド化合物 |
Country Status (27)
| Country | Link |
|---|---|
| US (8) | US7396935B2 (de) |
| EP (5) | EP2133348B1 (de) |
| JP (1) | JP4601611B2 (de) |
| KR (1) | KR20060022649A (de) |
| CN (1) | CN1816529A (de) |
| AT (2) | ATE482200T1 (de) |
| AU (1) | AU2004236240C1 (de) |
| BR (1) | BRPI0409949A (de) |
| CA (1) | CA2524321A1 (de) |
| CO (1) | CO5640039A2 (de) |
| DE (1) | DE602004029242D1 (de) |
| DK (1) | DK1618092T3 (de) |
| ES (3) | ES2350837T3 (de) |
| GE (1) | GEP20074236B (de) |
| HR (1) | HRP20100670T1 (de) |
| IS (1) | IS8101A (de) |
| MX (1) | MXPA05011666A (de) |
| NO (1) | NO20054970L (de) |
| NZ (1) | NZ543375A (de) |
| PL (1) | PL1618092T3 (de) |
| PT (1) | PT1618092E (de) |
| RS (1) | RS20050789A (de) |
| RU (1) | RU2342365C2 (de) |
| SI (1) | SI1618092T1 (de) |
| UA (1) | UA81668C2 (de) |
| WO (3) | WO2004098528A2 (de) |
| ZA (1) | ZA200508830B (de) |
Families Citing this family (92)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5859031A (en) * | 1995-06-07 | 1999-01-12 | Gpi Nil Holdings, Inc. | Small molecule inhibitors of rotamase enzyme activity |
| US7078419B2 (en) * | 2003-03-10 | 2006-07-18 | Boehringer Ingelheim Pharmaceuticals, Inc. | Cytokine inhibitors |
| ES2350837T3 (es) * | 2003-05-01 | 2011-01-27 | Bristol-Myers Squibb Company | Compuestos de pirazol-amida sustituidos con arilo útiles como inhibidores de quinasas. |
| WO2005012256A1 (en) | 2003-07-22 | 2005-02-10 | Astex Therapeutics Limited | 3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators |
| JP4824576B2 (ja) * | 2003-12-03 | 2011-11-30 | ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド | サイトカイン生成のインヒビターとしての１，２，３−トリアゾールアミド誘導体 |
| JP2007514759A (ja) * | 2003-12-19 | 2007-06-07 | タケダ サン ディエゴ インコーポレイテッド | キナーゼ阻害剤 |
| CA2557856C (en) * | 2004-03-09 | 2010-06-29 | Boehringer Ingelheim Pharmaceuticals, Inc. | 3-'4-heterocyclyl-1,2,3,-triazol-1-yl!-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases |
| US20050250829A1 (en) * | 2004-04-23 | 2005-11-10 | Takeda San Diego, Inc. | Kinase inhibitors |
| EP1745036A2 (de) * | 2004-05-03 | 2007-01-24 | Boehringer Ingelheim Pharmaceuticals Inc. | Cytokininhibitoren |
| US7485657B2 (en) * | 2004-05-12 | 2009-02-03 | Boehringer Ingelheim Pharmaceuticals, Inc. | Anti-cytokine heterocyclic compounds |
| US7550598B2 (en) * | 2004-08-18 | 2009-06-23 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
| WO2006040520A1 (en) | 2004-10-12 | 2006-04-20 | Astrazeneca Ab | Quinazoline derivatives |
| US7713973B2 (en) | 2004-10-15 | 2010-05-11 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
| US7531560B2 (en) * | 2004-11-10 | 2009-05-12 | Boehringer Ingelheim Pharmaceuticals, Inc. | Anti-cytokine heterocyclic compounds |
| US8404718B2 (en) | 2005-01-21 | 2013-03-26 | Astex Therapeutics Limited | Combinations of pyrazole kinase inhibitors |
| CN101203484B (zh) | 2005-06-21 | 2012-09-05 | 三井化学株式会社 | 酰胺衍生物及含有该化合物的杀虫剂 |
| US8119655B2 (en) | 2005-10-07 | 2012-02-21 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
| WO2007052843A1 (ja) * | 2005-11-04 | 2007-05-10 | Takeda Pharmaceutical Company Limited | 複素環アミド化合物およびその用途 |
| KR20080085183A (ko) * | 2005-12-22 | 2008-09-23 | 아스트라제네카 아베 | 화학적 화합물 |
| UY30183A1 (es) | 2006-03-02 | 2007-10-31 | Astrazeneca Ab | Derivados de quinolina |
| MY149622A (en) | 2006-03-22 | 2013-09-13 | Hoffmann La Roche | Pyrazoles as 11-beta-hsd-1 |
| MX2009003793A (es) | 2006-10-09 | 2009-12-14 | Takeda Pharmaceutical | Inhibidores de cinasa. |
| JP2010505961A (ja) * | 2006-10-09 | 2010-02-25 | タケダ サン ディエゴ インコーポレイテッド | キナーゼ阻害剤 |
| MX2009003821A (es) | 2006-10-10 | 2009-05-25 | Amgen Inc | Compuestos de n-aril pirazol para usarse contra la diabetes. |
| EP2083816A2 (de) * | 2006-10-27 | 2009-08-05 | Brystol-Myers Squibb Company | Heterocyclische amidverbindungen als kinasehemmer |
| JP2010508325A (ja) * | 2006-10-30 | 2010-03-18 | ノバルティス アーゲー | プロテインキナーゼの阻害剤として有用な３−アミノ−ピラゾール−４−カルボキサミド誘導体 |
| CN101611024A (zh) * | 2006-12-20 | 2009-12-23 | 百时美施贵宝公司 | 芳基-取代的吡唑-酰胺化合物的晶形 |
| US7737149B2 (en) | 2006-12-21 | 2010-06-15 | Astrazeneca Ab | N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereof |
| US7638541B2 (en) | 2006-12-28 | 2009-12-29 | Metabolex Inc. | 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine |
| WO2008118758A1 (en) | 2007-03-23 | 2008-10-02 | Icagen, Inc. | Inhibitors of ion channels |
| EP2134175A4 (de) * | 2007-03-29 | 2012-01-11 | Glaxosmithkline Llc | Hemmer von akt-aktivität |
| CL2008000979A1 (es) * | 2007-04-11 | 2008-10-17 | Sumitomo Chemical Co | Proceso para producir un compuesto derivado de 2-piridin-2-il-2h-pirazol-3-fenilamida; compuestos intermediarios; el compuesto en si; composicion plaguicida que contiene a dicho compuesto; uso de dicho compuesto como plaguicida; y metodo para control |
| EP1992344A1 (de) | 2007-05-18 | 2008-11-19 | Institut Curie | P38 Alpha als therapeutisches Target für Erkrankungen, die mit einer FGFR3- Mutation assoziiert sind |
| AU2008257559B2 (en) * | 2007-05-25 | 2013-10-10 | AbbVie Deutschland GmbH & Co. KG | Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (MGLU2 receptor) |
| WO2009010416A2 (en) | 2007-07-17 | 2009-01-22 | F. Hoffmann-La Roche Ag | Inhibitors of 11b-hydroxysteroid dehydrogenase |
| AU2008279447A1 (en) * | 2007-07-19 | 2009-01-29 | Metabolex, Inc. | N-azacyclic substituted pyrrole, pyrazole, imidazole, triazole and tetrazole derivatives as agonists of the RUP3 or GPR119 receptor for the treatment of diabetes and metabolic disorders |
| SA08290520B1 (ar) | 2007-08-22 | 2012-02-22 | استرازينيكا ايه بي | مشتقات سيكلو بروبيل أميد وتركيبات صيدلية تحتوي عليها لعلاج حالة مرضية سببها مستقبلات هيستامين h3 |
| US8080546B2 (en) | 2007-10-26 | 2011-12-20 | Amgen Inc. | Pyrazolo-pyridinone derivatives and methods of use |
| JP5450083B2 (ja) * | 2007-11-01 | 2014-03-26 | 武田薬品工業株式会社 | 複素環化合物 |
| MY158982A (en) * | 2008-03-05 | 2016-11-30 | Takeda Pharmaceuticals Co | Heterocyclic compound |
| CA2724294A1 (en) | 2008-05-16 | 2009-11-19 | Schering Corporation | Glucagon receptor antagonists, compositions, and methods for their use |
| EP2151434A1 (de) | 2008-08-05 | 2010-02-10 | Institut Pasteur | Allkoxypyrazole und Verfahren zu ihrer Herstellung |
| CN102186809A (zh) | 2008-08-14 | 2011-09-14 | 拜尔农作物科学股份公司 | 杀虫性的4-苯基-1h-吡唑 |
| EP2184273A1 (de) * | 2008-11-05 | 2010-05-12 | Bayer CropScience AG | Halogen-substituierte Verbindungen als Pestizide |
| WO2010071583A1 (en) * | 2008-12-18 | 2010-06-24 | Astrazeneca Ab | Pharmaceutical product comprising a p38 kinase inhibitor and a second active ingredient |
| AR073486A1 (es) * | 2009-02-06 | 2010-11-10 | Takeda Pharmaceutical | Compuesto heterociclico para diabetes |
| TW201039825A (en) | 2009-02-20 | 2010-11-16 | Astrazeneca Ab | Cyclopropyl amide derivatives 983 |
| ES2497566T3 (es) | 2009-10-01 | 2014-09-23 | Cymabay Therapeutics, Inc. | Sales de tetrazol-1-il-fenoximetil-tiazol-2-il-piperidinil-pirimidina sustituida |
| SG183274A1 (en) | 2010-02-18 | 2012-09-27 | Astrazeneca Ab | Processes for making cyclopropyl amide derivatives and intermediates associated therewith |
| WO2011126903A2 (en) | 2010-03-30 | 2011-10-13 | Verseon, Inc. | Multisubstituted aromatic compounds as inhibitors of thrombin |
| MA34234B1 (fr) * | 2010-04-07 | 2013-05-02 | Hoffmann La Roche | Composes pyrazol-4-yl-heterocyclyle-carboxamide et leurs procedes d'utilisation |
| JP2013526542A (ja) | 2010-05-12 | 2013-06-24 | アッヴィ・インコーポレイテッド | キナーゼのインダゾール阻害薬 |
| WO2012138809A1 (en) * | 2011-04-05 | 2012-10-11 | Dawei Zhang | Heterocyclic compounds as kinase inhibitors |
| EP2871179A4 (de) | 2012-07-03 | 2016-03-16 | Ono Pharmaceutical Co | Verbindung mit agonistischer wirkung auf den somatostatinrezeptor und ihre verwendung für medizinische zwecke |
| US9328116B2 (en) | 2012-12-07 | 2016-05-03 | Chemocentryx, Inc. | Diazole lactams |
| CA2894715C (en) | 2012-12-21 | 2021-06-15 | Chemocentryx, Inc. | Diazole amides |
| US20140179712A1 (en) | 2012-12-21 | 2014-06-26 | Astrazeneca Ab | Pharmaceutical formulation of n-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2h-pyrazol-3-yl]-4-[(3r,5s)-3,5-dimethylpiperazin-1-yl]benzamide |
| CN110423221A (zh) * | 2013-03-15 | 2019-11-08 | 维颂公司 | 作为凝血酶抑制剂的卤代吡唑 |
| MX2015011445A (es) | 2013-03-15 | 2016-04-20 | Global Blood Therapeutics Inc | Compuestos y usos de estos para la modulacion de la hemoglobina. |
| NZ711064A (en) | 2013-03-15 | 2019-06-28 | Verseon Corp | Pyridone-substituted pyrazolyl compounds as serine protease inhibitors |
| EA201992707A1 (ru) | 2013-11-18 | 2020-06-30 | Глобал Блад Терапьютикс, Инк. | Соединения и их применения для модуляции гемоглобина |
| EP3076789A4 (de) * | 2013-12-04 | 2017-11-22 | The Scripps Research Institute | Neuartige verbindungen als jnk-kinasehemmer |
| KR20160115933A (ko) | 2014-01-10 | 2016-10-06 | 오리진 디스커버리 테크놀로지스 리미티드 | Irak4 억제제로서의 인다졸 화합물 |
| SG10201811204RA (en) | 2014-01-13 | 2019-01-30 | Aurigene Discovery Tech Ltd | Bicyclic heterocyclyl derivatives as irak4 inhibitors |
| WO2015143653A1 (en) | 2014-03-26 | 2015-10-01 | Merck Sharp & Dohme Corp. | TrkA KINASE INHIBITORS,COMPOSITIONS AND METHODS THEREOF |
| WO2015143654A1 (en) | 2014-03-26 | 2015-10-01 | Merck Sharp & Dohme Corp. | TrkA KINASE INHIBITORS,COMPOSITIONS AND METHODS THEREOF |
| WO2015143652A1 (en) | 2014-03-26 | 2015-10-01 | Merck Sharp & Dohme Corp. | TrkA KINASE INHIBITORS,COMPOSITIONS AND METHODS THEREOF |
| WO2015150300A1 (de) | 2014-04-02 | 2015-10-08 | Bayer Cropscience Ag | N-(1-(hetero)aryl-1h-pyrazol-4-yl)-(hetero)arylamid-derivate und ihre verwendung als schädlingsbekämpfungsmittel |
| WO2015170218A1 (en) * | 2014-05-07 | 2015-11-12 | Pfizer Inc. | Tropomyosin-related kinase inhibitors |
| EP3143847B1 (de) * | 2014-05-14 | 2023-07-12 | AT & S Austria Technologie & Systemtechnik Aktiengesellschaft | Verfahren zum herstellen eines leiterzugs mit verbreiterungsfreiem übergang zwischen leiterbahn und kontaktstruktur |
| RU2583158C2 (ru) * | 2014-06-06 | 2016-05-10 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Пермский государственный национальный исследовательский университет" | Метил 5-(арилкарбамоил)-1-(бензил и фенил)-4-циннамоил-1н-пиразол-3-карбоксилаты, проявляющие анальгетическую активность, и способ их получения |
| KR20170016500A (ko) * | 2014-06-20 | 2017-02-13 | 오리진 디스커버리 테크놀로지스 리미티드 | Irak4 저해제로서의 치환된 인다졸 화합물 |
| WO2016044662A1 (en) | 2014-09-17 | 2016-03-24 | Verseon Corporation | Pyrazolyl-substituted pyridone compounds as serine protease inhibitors |
| HUE060104T2 (hu) | 2015-02-27 | 2023-01-28 | Verseon Int Corporation | Szubsztituált pirazol vegyületek mint szerinproteázinhibitorok |
| WO2016161572A1 (en) | 2015-04-08 | 2016-10-13 | Merck Sharp & Dohme Corp. | TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF |
| WO2016202935A1 (en) | 2015-06-19 | 2016-12-22 | Bayer Pharma Aktiengesellschaft | Glucose transport inhibitors |
| TWI758751B (zh) * | 2015-12-16 | 2022-03-21 | 日商日本曹達股份有限公司 | 芳基唑化合物及有害生物防除劑 |
| CA3019391A1 (en) | 2016-04-07 | 2017-10-12 | Chemocentryx, Inc. | Reducing tumor burden by administering ccr1 antagonists in combination with pd-1 inhibitors or pd-l1 inhibitors |
| EP3493807A1 (de) | 2016-08-03 | 2019-06-12 | CymaBay Therapeutics, Inc. | Oxymethylenarylverbindungen zur behandlung von entzündlichen gastrointestinalen krankheiten oder gastrointestinalen leiden |
| BR112019003320B1 (pt) | 2016-09-15 | 2024-02-20 | Boehringer Ingelheim International Gmbh | Compostos de heteroaril carboxamida, sal farmaceuticamente aceitável dos mesmos, composição farmacêutica e seus usos como inibidores de ripk2 |
| US10414753B2 (en) * | 2016-10-26 | 2019-09-17 | Rigel Pharmaceuticals, Inc. | Amide compounds and method for making and using |
| CN110139862B (zh) * | 2016-11-03 | 2024-01-16 | 百时美施贵宝公司 | 可用作romk通道抑制剂的经取代的二环杂环衍生物 |
| TWI795381B (zh) * | 2016-12-21 | 2023-03-11 | 比利時商健生藥品公司 | 作為ｍａｌｔ１抑制劑之吡唑衍生物 |
| KR102633530B1 (ko) | 2017-03-31 | 2024-02-02 | 오리진 온콜로지 리미티드 | 혈액 장애를 치료하기 위한 화합물 및 조성물 |
| CN114732910A (zh) | 2017-10-05 | 2022-07-12 | 弗尔康医疗公司 | P38激酶抑制剂降低dux4和下游基因表达以用于治疗fshd |
| US10342786B2 (en) | 2017-10-05 | 2019-07-09 | Fulcrum Therapeutics, Inc. | P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD |
| WO2019089580A1 (en) | 2017-10-31 | 2019-05-09 | Curis, Inc. | Compounds and compositions for treating hematological disorders |
| CN110028450A (zh) * | 2018-01-12 | 2019-07-19 | 沈阳中化农药化工研发有限公司 | 一种吡唑酰胺类化合物的制备方法 |
| AU2019247533B2 (en) * | 2018-04-06 | 2023-09-28 | Altos Labs, Inc. | ATF6 inhibitors and uses thereof |
| CA3104055A1 (en) | 2018-06-18 | 2019-12-26 | Janssen Pharmaceutica Nv | Pyrazole derivatives as malt1 inhibitors |
| CA3104053A1 (en) | 2018-06-18 | 2019-12-26 | Janssen Pharmaceutica Nv | Pyrazole derivatives as malt1 inhibitors |
| AU2020311940A1 (en) | 2019-07-11 | 2022-02-03 | ESCAPE Bio, Inc. | Indazoles and azaindazoles as LRRK2 inhibitors |
Family Cites Families (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4134987A (en) * | 1976-01-14 | 1979-01-16 | Huppatz John L | Compounds and compositions |
| US4200750A (en) | 1977-01-07 | 1980-04-29 | Westwood Pharmaceuticals Inc. | 4-Substituted imidazo [1,2-a]quinoxalines |
| JPH04316559A (ja) | 1990-11-28 | 1992-11-06 | Nissan Chem Ind Ltd | ピラゾールカルボキサニリド誘導体及び殺菌剤 |
| GB9816837D0 (en) | 1998-08-04 | 1998-09-30 | Zeneca Ltd | Amide derivatives |
| KR100214732B1 (ko) * | 1992-12-14 | 1999-08-02 | 세야 히로미치 | 유리제품의 성형 방법 및 장치 |
| US5739135A (en) | 1993-09-03 | 1998-04-14 | Bristol-Myers Squibb Company | Inhibitors of microsomal triglyceride transfer protein and method |
| US5760246A (en) | 1996-12-17 | 1998-06-02 | Biller; Scott A. | Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method |
| US6147080A (en) * | 1996-12-18 | 2000-11-14 | Vertex Pharmaceuticals Incorporated | Inhibitors of p38 |
| US6020357A (en) * | 1996-12-23 | 2000-02-01 | Dupont Pharmaceuticals Company | Nitrogen containing heteroaromatics as factor Xa inhibitors |
| AUPO622597A0 (en) * | 1997-04-15 | 1997-05-08 | Fujisawa Pharmaceutical Co., Ltd. | New heterocyclic compounds |
| US5998424A (en) * | 1997-06-19 | 1999-12-07 | Dupont Pharmaceuticals Company | Inhibitors of factor Xa with a neutral P1 specificity group |
| NZ502702A (en) * | 1997-09-23 | 2002-10-25 | Astrazeneca Ab | Amide derivatives for the treatment of diseases mediated by TNF, IL-1, IL-6 or IL-8 |
| US6316466B1 (en) | 1998-05-05 | 2001-11-13 | Syntex (U.S.A.) Llc | Pyrazole derivatives P-38 MAP kinase inhibitors |
| AU3859999A (en) | 1998-05-14 | 1999-11-29 | G.D. Searle & Co. | 1,5-diaryl substituted pyrazoles as p38 kinase inhibitors |
| US6200968B1 (en) | 1998-08-06 | 2001-03-13 | Cephalon, Inc. | Particle-forming compositions containing fused pyrrolocarbazoles |
| DK1115707T3 (da) * | 1998-09-25 | 2004-03-01 | Astrazeneca Ab | Benzamidderivater og deres anvendelse som cytokininhibitorer |
| JP2002531549A (ja) | 1998-12-04 | 2002-09-24 | ブリストル−マイヤーズ スクイブ カンパニー | カリウムチャネル・モジュレーターとしての３−置換−４−アリールキノリン−２−オン誘導体 |
| KR100659007B1 (ko) * | 1999-02-10 | 2007-02-28 | 미츠비시 웰파마 가부시키가이샤 | 아미드 화합물 및 그 의약으로서의 용도 |
| US6548529B1 (en) | 1999-04-05 | 2003-04-15 | Bristol-Myers Squibb Company | Heterocyclic containing biphenyl aP2 inhibitors and method |
| JP4627944B2 (ja) | 1999-06-03 | 2011-02-09 | あすか製薬株式会社 | 置換ピラゾール化合物 |
| FR2795726A1 (fr) * | 1999-06-30 | 2001-01-05 | Aventis Cropscience Sa | Nouveaux pyrazoles fongicides |
| DE60033684T2 (de) | 1999-11-18 | 2007-12-06 | Ajinomoto Co., Inc. | Phenylalaninderivate |
| MY125533A (en) | 1999-12-06 | 2006-08-30 | Bristol Myers Squibb Co | Heterocyclic dihydropyrimidine compounds |
| US6569885B1 (en) | 1999-12-23 | 2003-05-27 | Icos Corporation | Cyclic AMP-specific phosphodiesterase inhibitors |
| US6197492B1 (en) * | 1999-12-28 | 2001-03-06 | Eastman Kodak Company | Photographic element, compound, and process |
| US6194132B1 (en) * | 1999-12-28 | 2001-02-27 | Eastman Kodak Company | Photographic element, compound, and process |
| US20020065270A1 (en) | 1999-12-28 | 2002-05-30 | Moriarty Kevin Joseph | N-heterocyclic inhibitors of TNF-alpha expression |
| US6906067B2 (en) | 1999-12-28 | 2005-06-14 | Bristol-Myers Squibb Company | N-heterocyclic inhibitors of TNF-α expression |
| HN2001000008A (es) | 2000-01-21 | 2003-12-11 | Inc Agouron Pharmaceuticals | Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo |
| MY138097A (en) | 2000-03-22 | 2009-04-30 | Du Pont | Insecticidal anthranilamides |
| WO2002010146A1 (en) * | 2000-07-31 | 2002-02-07 | Smithkline Beecham P.L.C. | Carboxamide compounds and their use as antagonists of a human 11cby receptor |
| EP1329160A4 (de) * | 2000-08-25 | 2004-04-14 | Sankyo Co | 4-acylaminopyrazol-derivate |
| AU2001295789B2 (en) | 2000-10-30 | 2006-05-11 | Kudos Pharmaceuticals Ltd | Phthalazinone derivatives |
| GB0102687D0 (en) | 2001-02-02 | 2001-03-21 | Pharmacia & Upjohn Spa | Oxazolyl-pyrazole derivatives active as kinase inhibitors,process for their preparation and pharmaceutical compositions comprising them |
| WO2002088090A2 (en) * | 2001-04-27 | 2002-11-07 | Vertex Pharmaceuticals Incorporated | Pyrazole derived kinase inhibitors |
| DE60214703T2 (de) | 2001-06-01 | 2007-09-13 | Vertex Pharmaceuticals Inc., Cambridge | Thiazolverbindungen, die sich als inhibitoren von proteinkinasen eignen |
| JP4510442B2 (ja) | 2001-06-26 | 2010-07-21 | ブリストル−マイヤーズ スクイブ カンパニー | ＴＮＦ−α発現のＮ−ヘテロ環インヒビター |
| ATE455104T1 (de) | 2001-11-01 | 2010-01-15 | Icagen Inc | Pyrazolamide zur anwendung in der behandlung von schmerz |
| AU2002357137A1 (en) * | 2001-12-10 | 2003-06-23 | Bristol-Myers Squibb Company | (1-phenyl-2-heteroaryl)ethyl-guanidine compounds as inhibitors of mitochondrial f1f0 atp hydrolase |
| US6521395B1 (en) * | 2002-01-30 | 2003-02-18 | Eastman Kodak Company | Infrared couplers for incorporating and recovering metadata |
| WO2003064389A1 (fr) | 2002-01-31 | 2003-08-07 | Ono Pharmaceutical Co., Ltd. | Composes bicycliques contenant de l'azote et medicaments contenant ces composes en tant qu'ingredient actif |
| JP4595542B2 (ja) * | 2002-07-30 | 2010-12-08 | 萬有製薬株式会社 | ベンズイミダゾール誘導体を有効成分とするメラニン凝集ホルモン受容体拮抗剤 |
| PL374971A1 (en) | 2002-08-09 | 2005-11-14 | Transtech Pharma, Inc. | Aryl and heteroaryl compounds and methods to modulate coagulation |
| WO2004035545A2 (en) | 2002-10-18 | 2004-04-29 | E.I. Du Pont De Nemours And Company | Azolecarboxamide herbicides |
| US20060241157A1 (en) * | 2003-01-06 | 2006-10-26 | Conner Scott E | Heterocyclic ppar modulators |
| ES2349532T3 (es) | 2003-02-06 | 2011-01-04 | Bristol-Myers Squibb Company | Compuestos basados en tiazolilo útiles como inhibidores de cinasa. |
| ES2350837T3 (es) * | 2003-05-01 | 2011-01-27 | Bristol-Myers Squibb Company | Compuestos de pirazol-amida sustituidos con arilo útiles como inhibidores de quinasas. |
| WO2004106324A1 (en) | 2003-05-27 | 2004-12-09 | E.I. Dupont De Nemours And Company | Azolecarboxamide herbicides |
| US7419978B2 (en) | 2003-10-22 | 2008-09-02 | Bristol-Myers Squibb Company | Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitors |
| GB0329572D0 (en) | 2003-12-20 | 2004-01-28 | Astrazeneca Ab | Amide derivatives |
| US7491725B2 (en) | 2004-02-06 | 2009-02-17 | Bristol-Myers Squibb Company | Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors |
| US7652146B2 (en) | 2004-02-06 | 2010-01-26 | Bristol-Myers Squibb Company | Process for preparing 2-aminothiazole-5-carboxamides useful as kinase inhibitors |
| TWI338004B (en) | 2004-02-06 | 2011-03-01 | Bristol Myers Squibb Co | Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors |
| US20060069132A1 (en) | 2004-04-07 | 2006-03-30 | Armel Gregory R | Azolecarboxamide herbicides |
| WO2007002742A1 (en) | 2005-06-28 | 2007-01-04 | Pharmacopeia, Inc. | Substituted [1,4]-diazepanes as cxcr3 antagonists and their use in the treatment of inflammatory disorders |
-
2004
- 2004-05-03 ES ES04751133T patent/ES2350837T3/es not_active Expired - Lifetime
- 2004-05-03 ES ES04760705T patent/ES2386784T3/es not_active Expired - Lifetime
- 2004-05-03 CA CA002524321A patent/CA2524321A1/en not_active Abandoned
- 2004-05-03 EP EP09010209A patent/EP2133348B1/de not_active Expired - Lifetime
- 2004-05-03 KR KR1020057020642A patent/KR20060022649A/ko not_active Application Discontinuation
- 2004-05-03 EP EP04760683A patent/EP1617840A4/de not_active Withdrawn
- 2004-05-03 US US10/838,129 patent/US7396935B2/en active Active
- 2004-05-03 EP EP04751133A patent/EP1618092B1/de not_active Expired - Lifetime
- 2004-05-03 SI SI200431517T patent/SI1618092T1/sl unknown
- 2004-05-03 US US10/838,006 patent/US7151113B2/en active Active
- 2004-05-03 AT AT04751133T patent/ATE482200T1/de active
- 2004-05-03 UA UAA200511373A patent/UA81668C2/ru unknown
- 2004-05-03 JP JP2006514216A patent/JP4601611B2/ja not_active Expired - Fee Related
- 2004-05-03 AU AU2004236240A patent/AU2004236240C1/en not_active Ceased
- 2004-05-03 ES ES09010209T patent/ES2370463T3/es not_active Expired - Lifetime
- 2004-05-03 MX MXPA05011666A patent/MXPA05011666A/es active IP Right Grant
- 2004-05-03 AT AT09010209T patent/ATE522525T1/de not_active IP Right Cessation
- 2004-05-03 EP EP11005867.4A patent/EP2385041B1/de not_active Expired - Lifetime
- 2004-05-03 EP EP04760705A patent/EP1620108B1/de not_active Expired - Lifetime
- 2004-05-03 NZ NZ543375A patent/NZ543375A/en unknown
- 2004-05-03 PL PL04751133T patent/PL1618092T3/pl unknown
- 2004-05-03 PT PT04751133T patent/PT1618092E/pt unknown
- 2004-05-03 BR BRPI0409949-4A patent/BRPI0409949A/pt not_active IP Right Cessation
- 2004-05-03 DK DK04751133.2T patent/DK1618092T3/da active
- 2004-05-03 US US10/837,778 patent/US7414056B2/en active Active
- 2004-05-03 WO PCT/US2004/013786 patent/WO2004098528A2/en active Application Filing
- 2004-05-03 GE GEAP20049086A patent/GEP20074236B/en unknown
- 2004-05-03 WO PCT/US2004/013594 patent/WO2004098518A2/en active Application Filing
- 2004-05-03 WO PCT/US2004/013604 patent/WO2004099156A1/en active Application Filing
- 2004-05-03 DE DE602004029242T patent/DE602004029242D1/de not_active Expired - Lifetime
- 2004-05-03 CN CNA2004800188458A patent/CN1816529A/zh active Pending
- 2004-05-03 RS YUP-2005/0789A patent/RS20050789A/sr unknown
- 2004-05-03 RU RU2005135162/04A patent/RU2342365C2/ru not_active IP Right Cessation
-
2005
- 2005-10-26 NO NO20054970A patent/NO20054970L/no not_active Application Discontinuation
- 2005-10-28 IS IS8101A patent/IS8101A/is unknown
- 2005-10-31 ZA ZA200508830A patent/ZA200508830B/xx unknown
- 2005-11-01 CO CO05111218A patent/CO5640039A2/es not_active Application Discontinuation
-
2006
- 2006-06-28 US US11/477,010 patent/US7253170B2/en not_active Expired - Lifetime
-
2007
- 2007-08-02 US US11/832,924 patent/US7592338B2/en not_active Expired - Lifetime
- 2007-10-31 US US11/931,309 patent/US7390810B2/en not_active Expired - Lifetime
-
2008
- 2008-05-12 US US12/118,794 patent/US7605273B2/en not_active Expired - Lifetime
-
2009
- 2009-09-18 US US12/562,383 patent/US20100016320A1/en not_active Abandoned
-
2010
- 2010-12-06 HR HR20100670T patent/HRP20100670T1/hr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006525359A5 (de) | ||
| RU2005135162A (ru) | Арилзамещенные пиразоламиды в качестве ингибиторов киназ | |
| JP2005519932A5 (de) | ||
| JP3834236B2 (ja) | ピラゾロ〔４，３−ｄ〕ピリミジン誘導体 | |
| JPH02295978A (ja) | フェニルピリミドン誘導体 | |
| JP2004518763A5 (de) | ||
| JP2005505618A5 (de) | ||
| JP2000159749A5 (de) | ||
| JP2011502996A5 (de) | ||
| JP2013530150A5 (de) | ||
| JP2005508967A5 (de) | ||
| JP2004506611A5 (de) | ||
| JP2008523069A5 (de) | ||
| EP2412708A1 (de) | Substituiertes 3-hydroxy-4-pyridonderivat | |
| JP2005517655A (ja) | Ｃｂ１アンタゴニストとしての５，６−ジアリール−ピラジン−２−アミド誘導体 | |
| JP2014503574A5 (de) | ||
| JP2009539848A5 (de) | ||
| JP2014037426A5 (de) | ||
| JP2004504301A5 (de) | ||
| JP2009531292A5 (de) | ||
| JP2008509955A5 (de) | ||
| JP2001510154A5 (de) | ||
| TWI283667B (en) | Selective synthesis of CF3-substituted pyrimidines | |
| JP2009526037A (ja) | トリアゾロピリジン化合物 | |
| JP2018529690A5 (de) |